Tuesday, July 10, 2007

FDA approves patch to treat dementia

From CBC News:
The first patch to treat the dementia associated with Alzheimer's disease was approved Friday by the U.S. Food and Drug Administration.

The prescription patch from Novartis Pharmaceuticals Corp. contains the drug Exelon, or rivastigmine, currently available in Canada and the U.S. in an oral solution and in capsule form.

The oral and capsule medications have already been approved for use in both Alzheimer's and Parkinson's disease patients, to treat symptoms of mild to moderate dementia such as impaired thinking and memory loss. ...more

No comments: